given
interconnect
natur
world
today
emerg
pathogen
pandem
outbreak
evergrow
threat
health
econom
stabil
global
commun
evid
recent
influenza
pandem
sar
outbreak
well
everpres
threat
global
bioterror
fortun
biomed
commun
abl
rapidli
gener
sequenc
data
pathogen
readili
identifi
date
howev
util
sequenc
data
rapidli
produc
relev
experiment
result
action
treatment
lag
spite
obtain
sequenc
data
thu
pathogen
threat
emerg
andor
develop
pandem
rapidli
identifi
howev
translat
identif
target
therapeut
treatment
rapidli
avail
yet
materi
commentari
suggest
grow
technolog
dna
synthesi
fulli
implement
mean
rapidli
gener
vivo
data
possibl
action
therapeut
soon
sequenc
data
becom
avail
today
abil
determin
isol
viral
outbreak
could
develop
pandem
facilit
effici
pcr
sequenc
techniqu
quickli
identifi
character
pathogen
prompt
gener
sequenc
data
infect
individu
allow
identif
emerg
pathogen
center
diseas
control
cdc
world
health
organ
determin
emerg
pathogen
pose
pandem
threat
determin
base
earli
rate
infect
sequenc
data
similar
virul
factor
molecular
marker
take
exampl
recent
pandem
influenza
viru
identifi
mexico
rapidli
spread
countri
sampl
isol
sequenc
provid
immedi
analysi
sequenc
data
determin
origin
strain
genom
characterist
viru
thu
health
agenc
could
hypothes
inde
threat
global
commun
given
antigen
novelti
cdc
estim
pandem
infect
million
individu
major
individu
infect
experienc
mild
diseas
symptom
yet
estim
diseas
account
nearli
death
unit
state
us
alon
influenza
viru
continu
threat
caus
pandem
outbreak
given
abil
viru
reassort
via
phenomenon
antigen
shift
antigen
shift
result
host
infect
two
three
differ
influenza
strain
replic
host
virus
exchang
segment
genom
fragmentswap
could
yield
viru
antigen
profil
complet
novel
humanhost
popul
allow
rapid
spread
process
antigen
shift
hypothes
gener
event
viru
amazingli
viru
result
multipl
round
reassort
actual
combin
portion
avian
swine
human
influenza
virus
ultim
yield
viru
strain
spread
rapidli
across
globe
combin
segment
three
progenitor
strain
result
viru
highli
variabl
allow
rapid
transmiss
among
immunolog
humanhost
pandem
exampl
influenza
spread
across
globe
outbreak
includ
mild
regard
morbid
widespread
hong
kong
influenza
well
infam
spanish
influenza
pandem
sever
respons
estim
million
death
asid
influenza
pandem
entir
unrel
coronaviru
respons
signific
emerg
outbreak
spread
numer
locat
across
globe
wellpublic
sar
viru
initi
began
guangdong
provinc
china
spread
global
countri
initi
exact
viral
caus
sar
unknown
implement
viru
chip
wang
et
al
allow
identif
coronaviru
viru
estim
caus
agent
morbid
individu
result
mortal
rate
despit
extrem
differ
genet
composit
ie
influenza
rna
viru
coronavirus
rna
virus
share
characterist
crosstransmiss
virus
capabl
infect
rang
mammalian
avian
host
infect
human
usual
manifest
sever
upper
respiratori
diseas
exampl
virus
sar
identifi
character
base
sequenc
data
target
rapid
treatment
readili
produc
use
sequenc
inform
exampl
main
treatment
control
measur
implement
sar
simpli
isol
infect
individu
includ
quarantin
infect
individu
quarantin
patient
present
upperrespiratori
diseas
hospit
limit
travel
avoid
public
place
implement
strict
hygien
practic
hospit
disparag
good
hygien
effect
mean
combat
infect
given
current
medic
advanc
target
treatment
sought
combat
outbreak
first
line
treatment
also
rather
low
technolog
uninspir
administr
current
avail
antivir
oseltamivir
tamiflu
zanamivir
simpl
measur
schoolclosur
quarantin
implement
vaccin
product
slow
result
vaccin
avail
public
consumpt
late
fall
approxim
month
first
diagnos
case
mexico
time
vaccin
administ
viru
spread
global
infect
estim
million
peopl
us
alon
compound
lack
respons
persist
vaccin
shortag
highlight
ineffici
current
avail
treatment
repertoir
fortun
viru
rather
mild
howev
shortag
case
pandem
would
lead
higher
mortal
rate
well
civil
unrest
increas
panic
analyz
monthli
sequenc
data
patient
infect
may
oseltamivirresist
influenza
viru
isol
identifi
cdc
demonstr
antivir
resist
rapidli
emerg
resist
identifi
amino
acid
substitut
neuraminidas
gene
therefor
widespread
use
antivir
rapid
treatment
pandem
outbreak
may
prove
stopgap
complet
effect
initi
antivir
would
slow
progress
infect
resist
strain
emerg
treatment
would
prove
ineffect
first
isol
oseltamivirresist
strain
us
detect
week
august
four
month
first
case
report
mexico
thu
current
drugbas
therapi
may
prove
ineffect
especi
resist
strain
recombin
sever
viru
propos
har
rapid
dna
synthesi
develop
target
treatment
base
emerg
sequenc
approach
swift
clearanc
newli
emerg
pandem
strain
rapid
dna
synthesi
may
allow
adapt
respons
treatment
chang
along
mutat
pathogen
grant
regulatori
bodi
could
prove
hindranc
quick
develop
dissemin
novel
therapeut
agent
base
synthet
dna
howev
polici
may
chang
face
true
pandem
threat
flu
result
million
death
asid
known
pandem
threat
outlin
emerg
pathogen
also
threaten
local
global
commun
escap
current
begin
infect
larg
human
popul
previous
emerg
outbreak
would
limit
singl
geograph
locat
given
rise
global
travel
pathogen
could
impact
health
global
commun
exampl
emerg
pathogen
includ
outbreak
foodborn
pathogen
nosocomi
outbreak
ie
sar
toronto
origin
china
lastli
bioterrorist
agent
smallpox
erad
gener
popul
current
cdc
develop
entir
organ
design
divis
emerg
infect
surveil
servic
deiss
dedic
monitor
emerg
pathogen
appear
hope
identifi
caus
agent
contain
transmiss
asid
cdc
entir
research
institut
establish
focu
emerg
pathogen
impact
global
health
eg
global
health
emerg
pathogen
institut
mount
sinai
school
medicin
emerg
pathogen
institut
univers
florida
sinc
emerg
infecti
outbreak
come
zoonot
sourc
made
jump
human
host
effect
treatment
option
human
unknown
andor
poorli
character
howev
given
sequenc
data
could
quickli
gener
use
known
procedur
new
treatment
har
rapid
de
novo
dna
synthesi
may
mean
target
specif
combat
emerg
outbreak
aris
asid
obviou
widespread
morbid
mortal
pandem
occur
would
addit
econom
fall
would
also
detriment
impact
societi
cost
treat
patient
pandem
would
high
use
exampl
sar
impact
individu
extrem
exuber
polit
medic
respons
estim
cost
outbreak
rang
million
per
patient
signific
sum
realiz
small
quantiti
individu
infect
sar
outbreak
regard
pandem
influenza
outbreak
health
care
cost
alon
estim
rang
usd
billion
exclud
econom
impact
busi
analyz
pandem
outbreak
one
must
view
impact
economi
whole
one
studi
present
forum
conduct
australian
center
econom
research
health
perform
indepth
analysi
pandem
influenza
alter
global
econom
output
studi
sidorenko
et
al
divid
potenti
pandem
four
scenario
mild
moder
sever
ultra
base
mortal
rate
possibl
pandem
result
econom
consequ
divis
necessari
analyz
hypothet
pandem
potenti
econom
impact
vari
depend
sever
viru
estim
death
total
unit
state
four
scenario
would
thousand
respect
estim
multipli
estim
mortal
develop
countri
examin
estim
econom
impact
us
alon
estim
reduct
gross
domest
product
gdp
four
categori
respect
global
mild
pandem
like
current
viru
would
cost
usd
billion
gdp
ultra
pandem
akin
influenza
viru
estim
substanti
global
econom
impact
cost
usd
trillion
gdp
astound
econom
cost
result
decreas
product
chang
behavior
ie
avoid
public
place
go
work
etc
adjust
interest
rate
inflat
shear
shock
public
societi
specif
ultra
pandem
studi
estim
addit
rise
inflat
unit
state
decreas
export
basi
point
reduct
shortterm
interest
rate
given
us
first
world
societi
modern
health
care
system
capabl
combat
potenti
pandem
total
even
pronounc
look
project
develop
world
sum
develop
world
death
rate
gdp
reduct
would
far
greater
us
econom
impact
develop
world
would
substanti
due
shock
human
loss
life
well
flow
capit
emerg
market
safe
haven
us
eu
ultra
pandem
extrem
rare
event
one
never
hope
encount
astound
number
underscor
need
rapid
target
treatment
emerg
antivir
resist
strain
indic
need
har
dna
synthesi
mean
develop
target
therapeut
replac
current
antivir
de
novo
dnabas
therapeut
could
custom
sequenc
isol
field
allow
adapt
treatment
new
field
synthet
biolog
emerg
illumin
possibl
rapidli
gener
therapeut
agent
emerg
threat
aris
threaten
commun
globe
specif
scientif
commun
abil
synthes
de
novo
without
natur
templat
genet
materi
form
dna
enabl
synthet
biolog
door
open
vast
arena
new
experi
treatment
abil
custom
rapidli
gener
genet
materi
realiti
exampl
pathogen
synthet
design
genom
attenu
could
serv
vaccin
essenc
research
convert
digit
sequenc
data
biolog
relev
genet
materi
rel
short
order
current
cost
synthesi
approxim
cent
per
base
synthes
howev
given
rapid
improv
technolog
price
per
base
estim
decreas
throughout
decad
figur
compani
offer
complet
gene
synthesi
remark
number
resourc
util
research
laboratori
averag
place
nonrush
order
biotechnolog
compani
take
day
yield
kb
dna
howev
certain
compani
blue
herron
biotechnolog
geneart
advertis
sequenc
relat
viru
rapidli
gener
within
day
specif
press
releas
geneart
state
compani
rapidli
gener
gene
one
base
pair
viral
coat
protein
day
shear
speed
dna
gener
astound
indic
possibl
target
treatment
util
rapidli
gener
dna
readi
emerg
threat
short
period
time
therefor
new
method
combat
infecti
agent
must
nucleic
acidbas
thu
technolog
base
nucleic
acid
pursu
also
cost
effect
use
synthet
dnabas
therapeut
given
previou
method
develop
small
molecul
inhibitor
microb
previous
molecul
develop
screen
chemic
librari
effect
certain
pathogen
brute
forc
approach
drug
develop
could
wast
resourc
given
abil
synthes
genet
materi
target
specif
approach
taken
mean
longer
drug
develop
trial
error
rather
thought
target
manner
one
applic
dna
synthesi
would
gener
platform
deliveri
rnai
inhibit
infect
viru
specif
rna
could
synthes
rapidli
target
pathogen
thu
use
target
treatment
approach
method
success
control
plant
viru
infect
addit
vivo
work
shown
effect
mammal
specif
hepat
b
replic
control
infect
mice
numer
studi
shown
sirna
abl
slow
herp
replic
neuron
target
tissu
major
limit
deliveri
rna
molecul
still
requir
investig
howev
deliveri
hurdl
cross
advent
de
novo
nucleic
acid
synthesi
allow
rapid
target
product
order
inhibitor
rna
molecul
function
requir
high
sequenc
similar
target
given
virus
continu
mutat
singl
rna
molecul
would
function
treatment
unlik
howev
abl
quickli
gener
genet
materi
allow
construct
inhibitori
rna
intend
target
mutat
field
anoth
advantag
dna
synthesi
applic
studi
pathogen
vitro
previous
biomed
laboratori
reli
pcr
standard
mutagenesi
studi
viral
variant
aros
via
mutat
studi
focus
impact
mutat
either
viral
growth
vivo
pathogenesi
abil
mutat
confer
drug
resist
look
len
dna
synthesi
process
extrem
labori
given
small
number
mutat
could
studi
grant
import
find
thorough
work
result
use
method
howev
dna
synthesi
afford
us
abil
gener
vast
number
variat
sequenc
screen
biolog
relev
exampl
field
isol
sequenc
variat
could
gener
quickli
direct
studi
laboratori
allow
rapid
data
emerg
variant
thu
nucleotid
chang
seen
almost
realtim
clinic
isol
could
studi
laboratori
set
rapid
gener
sequenc
data
emerg
pathogen
may
also
serv
enhanc
prospect
peptideor
recombin
protein
rp
base
vaccin
one
readili
forese
applic
har
rapidli
gener
sequenc
data
mean
produc
target
graph
depict
decreas
price
per
base
larg
fragment
dna
synthesi
price
decreas
greater
applic
largescal
dna
synthesi
function
mean
combat
emerg
pandem
pathogen
price
indic
defin
us
dollar
peptid
rp
vaccin
emerg
threat
antigen
code
sequenc
attain
sequenc
emerg
pathogen
swiftli
har
dna
synthesi
translat
immedi
avail
peptid
vaccin
howev
current
drawback
low
immunogen
peptid
vaccin
weak
adjuv
andor
lack
optim
carrier
molecul
requir
enhanc
approach
peptideor
rpbase
vaccin
antiinfect
complet
viabl
recent
advanc
use
peptid
exampl
protect
peptid
vaccin
capabl
protect
anim
emerg
zoonot
pathogen
streptococcu
sui
serotyp
well
peptideinduc
immun
mycobacterium
tuberculosi
human
addit
util
recombin
viral
bacteri
vector
vaccin
adenoviru
vector
system
could
implement
quick
respons
vaccin
emerg
microb
recent
effort
util
replicationdefici
adenoviru
vector
possibl
hiv
vaccin
success
provid
enhanc
immun
hiv
nonhuman
primat
advantag
use
viral
vector
induc
strong
tcell
respons
antigen
interest
still
drawback
viral
vector
vaccin
requir
resolut
possibl
preexist
immun
vector
turn
prevent
immun
well
weak
humor
respons
vaccin
transgen
may
requir
protect
thu
like
peptid
vaccin
strategi
need
optim
viral
journal
pathogen
vector
readili
avail
system
capabl
rapid
use
emerg
pathogen
lastli
one
effect
treatment
infecti
diseas
avail
today
liveattenu
vaccin
success
decreas
morbid
mortal
across
globe
well
erad
human
pathogen
previous
liveattenu
vaccin
develop
serial
passag
virus
nonhuman
cell
render
less
pathogen
upon
return
humanhost
strategi
approach
reli
random
mutat
rather
userdirect
attenu
recent
synthet
biologist
recod
viral
pathogen
polioviru
influenza
viru
synonym
codonpair
mean
attenu
studi
codonpair
bia
polioviru
influenza
viru
alter
genom
level
viral
genom
translat
effici
downmodul
via
synthet
alter
larg
fragment
genom
recod
underrepres
ie
slow
codonpair
recod
maintain
amino
acid
ident
protein
level
yet
incorpor
nucleotid
level
synonym
mutat
ultim
alter
genom
translat
rate
abil
alter
genet
materi
macroscal
enabl
combin
function
genedesign
comput
softwar
largescal
dna
synthesi
synthet
modifi
virus
attenu
anim
model
accord
new
england
journal
medicin
method
hold
promis
platform
construct
liveattenu
vaccin
sinc
method
reli
dna
synthesi
univers
applic
comput
softwar
technolog
potenti
applic
yield
liveattenu
vaccin
viral
threat
emerg
sum
recent
seen
consid
pandem
influenza
threat
global
pandem
real
fortun
recent
outbreak
viru
reduc
pathogen
howev
heighten
biomed
commun
awar
treatment
contain
strategi
pandem
outbreak
must
improv
develop
includ
respons
rapid
natur
target
contain
spread
infect
commentari
suggest
implement
dna
synthesisbas
therapeut
strategi
deserv
seriou
consider
treatment
dna
synthesi
provid
target
adapt
target
treatment
could
rapidli
gener
adapt
viral
outbreak
mutat
